CNO
CNO Financial Group, Inc.
$52.89
+0.25 (+0.47%)
At close · Jul 7
Market Cap
$4.92B
Shares
93,348,503
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$52.89
Open$52.95
Day$52.88–53.55
52W$34.79–53.55
Avg vol 30d851K
Short int1.9M · 2.0% float · 2.3d
Short vol47%
Last earningsApr 30, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very Low
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+23%
above
Price vs 50-day avg
+10%
above
RSI (14)
68
neutral
MACD trend
Negative
52-week position
96%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+10%
trailing
6-month return
+24%
trailing
YTD return
+25%
this year
Relative strength
+16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $48 › 200d $43 — 50d above 200d
Institutional flow
Accumulating
12 of 361 funds reported for Jun 30 · net +723.9K sh shares · +1 new
Insider flow
Distributing
Net -$675.6K over 90 days · 100% sells
Short interest
Rising
2.05% of float · ▲ +4.7% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
361 holders — near 3-yr high, broad support
Squeeze score
40
low risk · 0–100
Fundamentals
Revenue growth
+1%
Y/Y
EPS growth
−41%
Y/Y
Valuation
P/E 21.2
rich
Buyback
$360.4M
remaining
Balance sheet
$260.2M
net debt
Quant / Vol
risk profile
Volatility
22%
annualized · 1-yr
Max drawdown
−11%
past year
ATR
1.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 1, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Guidance & track record
Latest guidance
· from the 8-K filed Apr 30, 2026
Operating EPS
· full-year 2026
Non-GAAP
Initiated
$4.25 – $4.45
Expense ratio
· full-year 2026
Initiated
18.8% – 19.2%
Effective tax rate
· full-year 2026
Initiated
22.5%
Free cash flow
· full-year 2026
Initiated
$200M – $250M
RBC Ratio
· full-year 2026
Initiated
360% – 390%
Holding company liquidity
· full-year 2026
Initiated
$150M
Debt to total capital ratio
· full-year 2026
Initiated
25% – 28%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+23%
Bullish
Price vs 50-day avg
+10%
Bullish
RSI (14)
68
Neutral
MACD trend
Negative
Bearish
52-week position
96%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $48 › 200d $43 — 50d above 200d
Institutional flow
Accumulating
12 of 361 funds reported for Jun 30 · net +723.9K sh shares · +1 new
Insider flow
Distributing
Net -$675.6K over 90 days · 100% sells
Short interest
Rising
2.05% of float · ▲ +4.7% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
361 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $35
Now $53 · 96%
52-wk high $54
vs 200-day avg +23%
vs 50-day avg +10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| annuity account values | 7% | Q1 2026 call | — |
| annuity collected premiums | $434M | Q1 2026 call | — |
| average book value of invested assets growth | 4.2% | Q1 2026 call | — |
| book value per diluted share, excluding AOCI | $38.98 | Q1 2026 call | — |
| brokerage client assets | 27% | Q1 2026 call | — |
| brokerage total accounts | 13% | Q1 2026 call | — |
| capital returned to shareholders | $77M | Q1 2026 call | — |
| debt to capital | 26.4% | Q1 2026 call | — |
| expense ratio | 18.9% | Q1 2026 call | — |
| holding company liquidity | $280M | Q1 2026 call | — |
| Life and Health NAP | 9% | Q1 2026 call | — |
| Life NAP | 1% | Q1 2026 call | — |
| Medicare supplement NAP | 53% | Q1 2026 call | — |
| net insurance liabilities and related assets growth | 4.8% | Q1 2026 call | — |
| net investment income growth | 6% | Q1 2026 call | — |
| new investments | $1.3B | Q1 2026 call | — |
| operating earnings per diluted share non-GAAP | $1.05 | Q1 2026 call | — |
| operating return on equity (trailing twelve months) non-GAAP | 13.1% | trailing twelve months Q1 2026 call | — |
| operating return on equity excluding significant items (trailing twelve months) non-GAAP | 12.2% | trailing twelve months Q1 2026 call | — |
| producing agent count | 3% | Q1 2026 call | — |
| reduction in weighted average diluted shares outstanding | 7% | Q1 2026 call | — |
| registered agent count | 7% | Q1 2026 call | — |
| share repurchases | $60M | Q1 2026 call | — |
| Supplemental health NAP | 10% | Q1 2026 call | — |
| total client assets | $18B | Q1 2026 call | — |
| Total Health NAP | 20% | Q1 2026 call | — |
| Total Medicare policies sold | 24% | Q1 2026 call | — |
| total new annualized premiums | 11% | Q1 2026 call | — |
| Worksite accident insurance NAP | 18% | Q1 2026 call | — |
| Worksite agent recruiting | 8% | Q1 2026 call | — |
| Worksite hospital indemnity insurance NAP | 121% | Q1 2026 call | — |
| Worksite Life and Health NAP | 22% | Q1 2026 call | — |
| Worksite life insurance NAP | 56% | Q1 2026 call | — |
| Worksite NAP from new clients | 65% | Q1 2026 call | — |
| Operating earnings per share growth non-GAAP | 11% | Full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNO
this stock
CNO Financial Group, Inc.
|
$4.92B | +25.1% | +0.9% | 21.2 | 2.0% |
|
CILJF
China Life Insurance Co Ltd
|
$106.28B | +7.8% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$68.96B | +15.3% | — | — | 0.8% |
|
AFL
Aflac Inc
|
$61.81B | +10.7% | -9.3% | 13.9 | 2.1% |
|
MET
Metlife Inc
|
$57.97B | +15.0% | +8.6% | 17.4 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNO | +1.5% | +10.4% | +23.7% | +3.8% | +25.1% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +0.6% | +9.0% | +16.1% | +3.6% | +15.4% |
Capital returns
Latest dividend
$0.18
/ share · ex Jun 10, 2026
Paid (TTM)
$0.69
/ share · 4 payouts
Dividend yield (TTM, derived)
1.30%
Buyback program
· as of Mar 31, 2026
Authorized
$500.00M
Spent (derived)
$139.60M
Remaining
$360.40M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1224608
CUSIP
12621E103
13F (30d)
13 filings
13 filers
Visit website
Investor relations